Subchronic toxicity study of dicyclopentadiene vapor in rats.
Fischer 344 rats were exposed by inhalation to 0, 1, 5 or 50 ppm dicyclopentadiene (DCPD) vapor 6 hr/day, 5 days/week for 13 weeks, followed by a 13-week recovery period. Animals were euthanized following completion of exposure at 2, 6, or 13 weeks and at postexposure weeks 4 or 13. No mortality, overt signs, body weight changes, hematologic or clinical chemistry values were related to DCPD exposure. In the high-exposure male rats, relative liver weights were significantly increased but with no accompanying histopathologic changes. Exposure to DCPD produced adverse kidney effects in male, but not female, rats as evidenced by the excretion of epithelial cells in the urine. Histologic changes were localized to the proximal tubules of the kidney and included increased accumulation of protein droplets, regenerative epithelium, and the presence of intraluminal proteinaceous material. In addition, several alterations in renal function were observed. Urinary Na+ excretion rates were decreased and urinary K+ excretion rates were increased throughout the exposure period; however, glucose was not present in the urine, and creatinine clearance was normal. The ability of the kidney to concentrate urine was also impaired. After the recovery period, many of the treatment-related kidney effects were not observed, including the presence of hyaline droplets in the proximal tubules and epithelial cells in the urine. These findings indicate an overall low degree of systemic toxicity following subchronic inhalation exposure of dicyclopentadiene at exposure levels up to 50 ppm. The only effect that was observed was a male rat-specific nephropathy that is characteristic of the hyaline droplet nephropathy produced by a diverse group of compounds.
Bevan
C
C
Exxon Biomedical Sciences, Inc., East Millstone, NJ 08875, USA.
Snellings
W M
WM
Dodd
D E
DE
Egan
G F
GF
D000280:Administration, Inhalation; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004847:Epithelial Cells; D005260:Female; D006818:Hyalin / Q000378:metabolism; D007192:Indenes / Q000008:administration & dosage / Q000633:toxicity*; D007687:Kidney Tubules, Proximal / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D008099:Liver / Q000187:drug effects; D008297:Male; D008854:Microscopy, Electron; D009929:Organ Size / Q000187:drug effects; D009994:Osmolar Concentration; D011188:Potassium / Q000652:urine; D011507:Proteinuria; D051381:Rats; D011916:Rats, Inbred F344; D012737:Sex Factors; D012964:Sodium / Q000652:urine; D014554:Urination / Q000187:drug effects; D014835:Volatilization; D014874:Water Pollutants, Chemical / Q000633:toxicity*
D007192:Indenes; D014874:Water Pollutants, Chemical; C004689:dicyclopentadiene; D012964:Sodium; D011188:Potassium